OCATA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Ocata Therapeutics, Inc. (OCAT) Over the Propos...
November 12 2015 - 4:09PM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of Ocata Therapeutics, Inc.
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of Ocata Therapeutics, Inc. (“Ocata” or the “Company”)
(NasdaqGM:OCAT) for potential breaches of fiduciary duties in
connection with the sale of the Company to Astellas Pharma Inc. for
approximately $379 million.
The Company’s stockholders will only receive $8.50 per share in
cash for each share of Company common stock they own. However the
offer is below at least one analyst’s target price of $9.00 per
share.
Click here for more information:
www.faruqilaw.com/OCAT. There is no cost or
obligation to you.
The investigation focuses on whether Ocata’s Board of Directors
breached their fiduciary duties to the Company’s stockholders by
failing to conduct a fair sales process and whether and by how much
this proposed transaction undervalues the Company to the detriment
of Ocata’s shareholders.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, throughout all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients. Follow us on Twitter at
www.twitter.com/MergerActivity or on Facebook at
www.facebook.com/FaruqiLaw.
If you own common stock in Ocata and wish to obtain additional
information and protect your investments free of charge, please
visit us at www.faruqilaw.com/OCAT or contact Juan Monteverde, Esq.
either via e-mail at jmonteverde@faruqilaw.com or by telephone at
(877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2015 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151112006533/en/
Faruqi & Faruqi, LLP369 Lexington Avenue, 10th FloorNew
York, NY 10017Attn: Juan Monteverde,
Esq.jmonteverde@faruqilaw.comToll Free: (877) 247-4292Phone: (212)
983-9330
Ocata Therapeutics, Inc. (NASDAQ:OCAT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ocata Therapeutics, Inc. (NASDAQ:OCAT)
Historical Stock Chart
From Sep 2023 to Sep 2024